Suppr超能文献

接受药物治疗联合/不联合部分囊切除术的犬移行细胞癌的临床转归。

Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy.

机构信息

Hope Veterinary Specialists, Surgery Department, 40 Three Tun Road, Malvern, Pennsylvania 19355, USA (Bradbury, Mullin, May, Clifford); Koret School of Veterinary Medicine, The Hebrew University in Jerusalem, Yehoshua Hankin St 21, Rehovot 76100, Israel (Gillian); The Animal Medical Center, Interventional Radiology and Endoscopy, 510 East 62nd Street, New York, New York 10065, USA (Weisse); Katonah Bedford Veterinary Center, Medical Oncology Department, 546 Bedford Road, Bedford Hills, New York 10507, USA (Bergman); Red Bank Veterinary Hospital, Medical Oncology Department, 197 Hance Avenue, Tinton Falls, New Jersey 07724, USA (Morges); Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, Wisconsin 53706, USA (Vail).

出版信息

Can Vet J. 2021 Feb;62(2):133-140.

Abstract

The objective of this retrospective study was to evaluate the effects of surgery on outcome for dogs with naturally occurring urinary bladder transitional cell carcinoma. Forty-seven dogs met the inclusion criteria. Thirty-one dogs (Group A) were treated with partial cystectomy and adjunctive medical therapy and 16 dogs (Group B) were treated with medical therapy alone. Overall survival was greater in dogs treated with partial cystectomy and adjunctive medical therapy (498 days for Group A 335 days for Group B, hazard ratio 2.5; 95% confidence interval: 1.1 to 5.7; = 0.026). Progression-free survival was not different between groups (85 days for Group A 83 days for Group B; = 0.663). No prognostic factors were identified for progression-free survival. Due to the many cases in Group A that were lost to follow-up, time-to-event survival analysis was performed. No significant difference in overall survival was noted, and no prognostic factors were identified in the time-to-event analysis. Prospective, randomized studies are needed to determine the role of partial cystectomy in the treatment of transitional cell carcinoma.

摘要

本回顾性研究的目的是评估手术对自然发生的犬膀胱移行细胞癌的疗效。47 只狗符合纳入标准。31 只狗(A 组)接受部分膀胱切除术和辅助药物治疗,16 只狗(B 组)仅接受药物治疗。接受部分膀胱切除术和辅助药物治疗的犬的总生存时间更长(A 组为 498 天,B 组为 335 天,风险比为 2.5;95%置信区间:1.1 至 5.7;P=0.026)。两组之间的无进展生存时间无差异(A 组为 85 天,B 组为 83 天;P=0.663)。未确定无进展生存的预后因素。由于 A 组中有许多病例失访,因此进行了时间事件生存分析。总生存时间无显著差异,时间事件分析中也未确定预后因素。需要进行前瞻性、随机研究来确定部分膀胱切除术在治疗移行细胞癌中的作用。

相似文献

2
Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder.
Vet Comp Oncol. 2017 Dec;15(4):1417-1427. doi: 10.1111/vco.12286. Epub 2017 Feb 20.
5
Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog.
Vet Surg. 2014 Mar;43(3):294-300. doi: 10.1111/j.1532-950X.2014.12104.x. Epub 2014 Jan 16.
6
Partial cystectomy for urinary bladder neoplasia: surgical technique and outcome in 11 dogs.
J Small Anim Pract. 1996 Oct;37(10):480-5. doi: 10.1111/j.1748-5827.1996.tb01745.x.
7
Interventions and experience after complicated total cystectomy in a dog with transitional cell carcinoma.
Vet Surg. 2020 May;49(4):811-817. doi: 10.1111/vsu.13330. Epub 2019 Oct 10.
8
Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
J Small Anim Pract. 2013 Feb;54(2):67-74. doi: 10.1111/jsap.12009. Epub 2013 Jan 3.

引用本文的文献

1
High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1.
Front Oncol. 2025 May 28;15:1590073. doi: 10.3389/fonc.2025.1590073. eCollection 2025.
2
Treatment outcomes of dogs with transitional cell carcinoma.
Front Vet Sci. 2025 Apr 25;12:1486786. doi: 10.3389/fvets.2025.1486786. eCollection 2025.
4
A Systematic Review of Canine Cystectomy: Indications, Techniques, and Outcomes.
Animals (Basel). 2023 Sep 13;13(18):2896. doi: 10.3390/ani13182896.

本文引用的文献

2
Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder.
Vet Comp Oncol. 2017 Dec;15(4):1417-1427. doi: 10.1111/vco.12286. Epub 2017 Feb 20.
7
Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010).
J Am Vet Med Assoc. 2013 Feb 15;242(4):499-506. doi: 10.2460/javma.242.4.499.
8
Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
J Small Anim Pract. 2013 Feb;54(2):67-74. doi: 10.1111/jsap.12009. Epub 2013 Jan 3.
9
Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.
J Vet Intern Med. 2012 Jul-Aug;26(4):987-95. doi: 10.1111/j.1939-1676.2012.00946.x. Epub 2012 May 25.
10
Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.
J Vet Intern Med. 2011 Nov-Dec;25(6):1385-90. doi: 10.1111/j.1939-1676.2011.00796.x. Epub 2011 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验